Coexistent anti-GFAP and anti-MOG antibodies presenting with isolated meningitis and papillitis: more support for

Andrew J Martin1, James Strathdee1, Nigel Wolfe1

  • 1Neurology Department, Blacktown Hospital, Blacktown, New South Wales, Australia.

BMJ Neurology Open
|April 11, 2022
PubMed
Abstract

Insights

This case report details a rare instance of co-occurring anti-myelin oligodendrocyte glycoprotein (MOG) and anti-glial fibrillar acidic protein (GFAP) antibodies. This finding expands the known spectrum of these autoimmune neurological conditions.

Area of Science:

  • Neuroimmunology
  • Autoimmune Neurology

Background:

  • Anti-myelin oligodendrocyte glycoprotein (MOG)-associated disorders and anti-glial fibrillar acidic protein (GFAP) conditions are distinct central nervous system demyelinating diseases.
  • While multiple autoantibodies can coexist, the simultaneous presence of MOG and GFAP antibodies is exceptionally rare, with only two prior reports.
  • GFAP-associated conditions typically present as severe meningoencephalomyelitis with papillitis.

Purpose of the Study:

  • To report the third known case of overlapping anti-GFAP and anti-MOG antibody-associated syndrome.
  • To contribute to the understanding of the phenotypic spectrum of these rare autoimmune disorders.
  • To highlight the potential for overlapping pathophysiological mechanisms.

Main Methods:

  • A case study of a 53-year-old male patient presenting with neurological symptoms.
  • Cerebrospinal fluid analysis for autoantibodies, including anti-GFAP and anti-MOG.
  • Comprehensive immunological and infectious workup.
  • Neurological imaging.

Main Results:

  • The patient presented with headache, fevers, and asymptomatic papillitis, later diagnosed with self-limited lymphocytic meningitis.
  • Cerebrospinal fluid testing revealed the presence of both anti-GFAP and anti-MOG antibodies.
  • The patient achieved a full recovery without requiring immunotherapy.
  • Extensive investigations for other causes were negative, and imaging was largely unremarkable.

Conclusions:

  • This case represents the third documented instance of co-occurring anti-GFAP and anti-MOG antibodies, expanding the recognized phenotype.
  • Clinicians should consider testing for both GFAP and MOG antibodies in unexplained meningitis, especially when accompanied by papillitis.
  • This case may offer insights into the underlying pathophysiology of these distinct yet potentially overlapping autoimmune conditions.